ZA959123B - Novel peptides derived from autoantigen for use immunotherapy of autoimmune diseases - Google Patents

Novel peptides derived from autoantigen for use immunotherapy of autoimmune diseases

Info

Publication number
ZA959123B
ZA959123B ZA959123A ZA959123A ZA959123B ZA 959123 B ZA959123 B ZA 959123B ZA 959123 A ZA959123 A ZA 959123A ZA 959123 A ZA959123 A ZA 959123A ZA 959123 B ZA959123 B ZA 959123B
Authority
ZA
South Africa
Prior art keywords
autoantigen
autoimmune diseases
peptides derived
novel peptides
use immunotherapy
Prior art date
Application number
ZA959123A
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA959123B publication Critical patent/ZA959123B/en

Links

ZA959123A 1994-10-27 1995-10-27 Novel peptides derived from autoantigen for use immunotherapy of autoimmune diseases ZA959123B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94203128 1994-10-27

Publications (1)

Publication Number Publication Date
ZA959123B true ZA959123B (en) 1997-01-23

Family

ID=8217321

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959123A ZA959123B (en) 1994-10-27 1995-10-27 Novel peptides derived from autoantigen for use immunotherapy of autoimmune diseases

Country Status (2)

Country Link
BR (1) BR1100903A (en)
ZA (1) ZA959123B (en)

Also Published As

Publication number Publication date
BR1100903A (en) 2001-11-06

Similar Documents

Publication Publication Date Title
HUP9903378A3 (en) Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
GB9712892D0 (en) Identification of mhc binding peptides
GB9617021D0 (en) Novel peptides for treatment of inflammation and shock
ZA9410083B (en) Methods of inhibiting autoimmune diseases
EP0478101A3 (en) Therapeutic use of peptides having thrombospondin-like activity
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
IL105153A0 (en) Peptides useful for tolerization
HUP9903961A3 (en) Tripeptide intermediates of antithrombotic azacycloalkylalkanoyl peptides
ZA977399B (en) Preparation of biuret-functional polyisocycanates from (cyclo) aliphatic diisocyanates
GB2241167B (en) Therapeutic use of somatostatin peptides
IL129024A0 (en) Use of proteins as agent against autoimmune diseases
HU9903292D0 (en) Remedy for autoimmune diseases
EP0828503A4 (en) Treatment for inhibiting the progression of autoimmune disease
EP0837691A4 (en) Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
HUP9802834A3 (en) Preparations for the treatment of t cell mediated autoimmune diseases
ZA959123B (en) Novel peptides derived from autoantigen for use immunotherapy of autoimmune diseases
IL116973A0 (en) Extraction of recombinant proteins
HUP9801680A3 (en) Peptides and remedy for autoimmune diseases comprising the same
HUP0103384A3 (en) Novel peptides for use in immunotherapy of autoimmune diseases
NZ273815A (en) Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides
IL127080A0 (en) The use of peptides derived from zona pelucida proteins for contraception and pharmaceutical compositions containing the same
AU4017389A (en) Use of paf-antagonists for treating autoimmune diseases
PL316288A1 (en) Peptides suitable to inhibit liberation of pepsin
HUP9904268A3 (en) Use of proteins as agents against autoimmune diseases
SI0928197T1 (en) Use of proteins as agents against autoimmune diseases